Cimex Lectularius or Bed Bugs : Vector of Infectious Agents and Pathogenic Role

Sting Clinical Trial

Official title:

Cimex Lectularius or Bed Bugs : Vector of Infectious Agents and Pathogenic Role

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01089465
• Other study ID #: 09-API-01
• Status: Completed
• Phase: N/A
• Start date: March 2010
• Est. completion date: December 31, 2019

Study information

• Verified date: April 2024
• Source: Centre Hospitalier Universitaire de Nice
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

During the last years, the investigators were the witness to the increase of a old emerging pest due to bed bugs (Cimex lectularius) in the world. Insecticides resistances apparitions and internationals transports increases seem to be the reasons of the pest. Cimex lectularius as vector of parasites, bacteria or virus was often suggested although not much observation are recently investigated in France. This study intends to examine the vectorial ability and the direct pathogenicity of Cimex lectularius.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 135
• Est. completion date: December 31, 2019
• Est. primary completion date: March 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• On the site of takings presence of insects and eggs evoking bedbugs of beds. The identification of certainty will be made in the laboratory. All the insects not apartment to the family of Cimicidae (Criterion of exclusion) are thrown(cast) in trash cans of laboratories for organic products.

• voluntary Patients after reading of the information sheet and the signature of the consent

• Membership of the patient in the national insurance scheme

Exclusion Criteria

• On the site of takings absence of insects and eggs evoking bedbugs of beds

• During the identification of certainty in the laboratory, the captured insects do not make parties of the family of Cimicidae

• The subjects deprived of freedom.

• Patients cancelling their consent.

• Patients violating the protocol of search(research)

Related Conditions & MeSH terms

• Communicable Diseases
• Infections
• Sting

Intervention

Other:
• Collection of the bedbugs and dermatological follow-up of the stings
Collection of the bedbugs and dermatological follow-up of the stings at J1 J7 J14 J21 J28

Locations

Country	Name	City	State
France	Collection of the bedbugs and dermatological follow-up of the stings	Nice

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Morphological identification of every bedbug Porterage of bacterial agents Porterage of viral agents Biomolecular identification of the insect A breeding of bedbugs Tests of sensibility in insecticides		day 1
Secondary	Study of the direct pathogenicity of lectularius C.	During each of four consultations a questionnaire and a descriptive index card(form) of the general and dermatological signs will be informed. The criteria of evaluation, associated with anonimisées photos, are split into two groups: general Signs and dermatological Signs	day 1, 7, 15 and 30